1. Volume 57, Pages S32-S37 (April 2000)
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy 
Hendrik Bos, Steen Andersen, Peter Rossing, Dick de Zeeuw, Hans-Henrik Parving, Paul E. de Jong, Gerjan Navis 
Kidney International 
Volume 57, Pages S32-S37 (April 2000)
DOI: /j x
Copyright © 2000 International Society of Nephrology Terms and Conditions

2. Figure 1
Individual antiproteinuric efficacy. In diabetic patients (IDDM), efficacy is presented as percentage change in albuminuria. In nondiabetic patients (NDRD), efficacy is presented as percent change in proteinuria. Symbols are: (•), ACE inhibitor vs. AT1 receptor blockade in IDDM; (▴), ACE inhibitor vs. AT1 receptor blockade in NDRD; (▪), ACE inhibitor vs. NSAID combined with alpha-methyldopa in NDRD.
Kidney International  , S32-S37DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

3. Figure 2
Individual antihypertensive efficacy presented as percentage change in diabetic patients (IDDM; •) and in nondiabetic renal disease (NDRD; ▴, ACE inhibitor vs. AT1 receptor blockade; ▪, ACE inhibitor vs. NSAID combined with alpha-methyldopa).
Kidney International  , S32-S37DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions

4. Figure 3
Individual antiproteinuric responses to the two different doses of ACE inhibitor (A) and AT1 receptor blockade (B) for diabetic (IDDM, •) and nondiabetic patients (▪). The continuous line represents the line of identity.
Kidney International  , S32-S37DOI: ( /j x)
Copyright © 2000 International Society of Nephrology Terms and Conditions